OSE fundamentals
An in-depth look to OSE IMMUNOTHERAPEUTICS operating, investing, and financing activities
OSE free cash flow for H1 24 is 66.61 M EUR. For 2023, OSE free cash flow was -20 M EUR and operating cash flow was -19.76 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM